ALPS Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21,665
| Closed | -$269K | – | 1079 |
|
|
2023
Q2 | $269K | Buy |
21,665
+165
| +0.8% | +$2.05K | ﹤0.01% | 927 |
|
|
2023
Q1 | $301K | Buy |
+21,500
| New | +$301K | ﹤0.01% | 872 |
|
|
2022
Q3 | – | Sell |
-8,978
| Closed | -$255K | – | 1152 |
|
|
2022
Q2 | $255K | Sell |
8,978
-93
| -1% | -$2.64K | ﹤0.01% | 934 |
|
|
2022
Q1 | $320K | Buy |
9,071
+1,132
| +14% | +$39.9K | ﹤0.01% | 745 |
|
|
2021
Q4 | $333K | Buy |
7,939
+158
| +2% | +$6.63K | ﹤0.01% | 808 |
|
|
2021
Q3 | $382K | Buy |
+7,781
| New | +$382K | ﹤0.01% | 603 |
|